Brivanib (BMS-540215) is an ATP-competitive inhibitor targeting VEGFR2 with an IC50 of 25 nM, exhibiting moderate potency against VEGFR-1 and FGFR-1, and over 240-fold selectivity against PDGFR-beta. Phase 3.
Molecular Weight:
370.38
Purity:
0.9887
CAS Number:
[649735-46-6]
Formula:
C19H19FN4O3
Target:
FGFR|||VEGFR|||EGFR|||Autophagy
* VAT and and shipping costs not included. Errors and price changes excepted